Market Tracker

04/25 5:16pm ET

Redhill Biopharma Ltd (NASDAQ:RDHL)

10.27
Delayed Data
As of 3:59pm ET
 +0.05 / +0.49%
Today’s Change
8.78
Today|||52-Week Range
16.54
-1.82%
Year-to-Date
No recent news for Redhill Biopharma Ltd.

Today’s Trading

Previous close10.22
Today’s open10.25
Day’s range10.16 - 10.37
Volume19,306
Average volume (3 months)73,281
Market cap$174.3M
Dividend yield--
Data as of 3:59pm ET, 04/25/2017

Growth & Valuation

Earnings growth (last year)-21.48%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+3,278.54%
P/E ratio--
Price/Sales1,329.82
Price/Book2.69

Competitors

 Today’s
change
Today’s
% change
OCXOncoCyte Corp0.000.00%
PPHMPeregrine Pharmaceut...+0.01+1.23%
ABUSArbutus Biopharma Co...+0.05+1.52%
FBIOFortress Biotech Inc+0.29+8.84%
Data as of 3:59pm ET, 04/25/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)-$0.45
Annual revenue (last year)$101.3K
Annual profit (last year)-$29.5M
Net profit margin-29,079.21%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Dror Ben-Asher
Chief Operating Officer
Gilead Raday
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts